AIM at Melanoma proudly collaborates with our Canadian partner, the Save Your Skin Foundation on presenting this informational webinar on ocular/uveal melanoma.

Date & Time: September 25, 7:00–7:30 PM (ET)

Hosted by: Richard D. Carvajal, MD, Melanoma and Cutaneous Oncology, Early Drug Development, Northwell Health Cancer Institute

Featuring:

• Marcus Butler, MD, board- certified medical oncologist at the Princess Margaret Cancer Centre in Toronto, Canada and Assistant Professor at the University of Toronto
• Suthee Rapisuwon, MD, board-certified medical oncologist, medical geneticist, and hematologist at MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center
• Jose Lutzky, MD, triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center

What You’ll Learn:

Join leading ocular/uveal melanoma specialists for a patient-friendly webinar about the latest treatments and clinical trials. This webinar will cover:

• Current adjuvant treatment options for uveal melanoma
• Two new clinical trials now open for patients with high-risk disease:
  • Tebentafusp trial
  • Quisinostat trial
• Plans for a key upcoming trial testing ipi/nivo therapy after primary treatment to reduce the risk of recurrence, as well as other trials currently in development
• How these trials aim to improve outcomes and provide more personalized care
• Expert perspectives on the future of ocular melanoma research and treatment
  

Join us to hear from melanoma specialists, ask questions, and learn about the latest treatment options and clinical trials for ocular/uveal melanoma.